In addition, co-expression of both EGFR and NeuGcGM3 ganglioside (30-70 %) was observed in others tumors with small number of patients but of different origin as sarcomas (n = 3) and non-Hodgkin lymphomas (n = 3). Here, EGFR is linked to sarcoma.